New Evolution in The Management of Atopic Dermatitis

المقدمة

سجل الان

We are pleased to invite you to the webinar titled ‘New Evolution in the Management of Atopic Dermatitis’ presented by Prof. Kristian Reich.

الأهداف

Prof. Kristian Reich will discuss:
- why targeting JAK1/2 in atopic dermatitis improves atopic dermatitis skin signs and symptoms.
- what implications targeting JAK1/2 might have on safety signals.
- the importance of interpreting safety concerns as well as JAK selectivity in the context of the safety profile in clinical trials.
- what implication Baricitinib molecule characteristics beyond JAK inhibition have on clinical practice.

المتحدثين

Professor Dr. med. Kristian Reich

Professor for Translational Research in Inflammatory Skin Diseases
Institute for Health Services Research in Dermatology and Nursing, University Medical Center Hamburg-Eppendorf
Physician